Yubo International Biotech YBGJ Cash Flow Statement (2009-2026)

OTC YBGJ
$0.01 +0.00 (+0.00%)
At close: Nov 12, 2026 · 4:00 PM EST
Reported Financials

Yubo International Biotech Quarterly Cash Flow Statement

Periods 71 quarters
Latest Sep 2026

Yubo International Biotech reported cash from operations of -$0.00M and free cash flow of -$0.00M for the quarter ended Sep 2026, up 100.0% year over year. This cash flow statement covers 71 quarters of results from Feb 2009 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Feb2009 May2009 Aug2009 Nov2009 Feb2010 May2010 Aug2010 Nov2010 Feb2011 May2011 Aug2011 Nov2011 Feb2012 May2012 Aug2012 Nov2012 Feb2013 May2013 Aug2013 Nov2013 Feb2014 May2014 Aug2014 Nov2014 Feb2015 May2015 Aug2015 Nov2015 Feb2016 May2016 Aug2016 Nov2016 Feb2017 May2017 Aug2017 Nov2017 Feb2018 May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Mar2020 May2020 Aug2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Operating Activities
Net Income
2.69M-0.58M-0.49M-0.24M0.10M-0.32M-0.37M0.01M-1.87M-0.41M-0.60M-0.62M3.61M-0.47M-0.25M-0.31M2.09M-0.30M-0.27M-0.20M
Depreciation and DepletionDep. & Depletion
0.00M0.00M0.01M-0.01M0.16M0.04M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.05M0.12M0.05M0.05M0.05M0.04M0.04M0.05M0.04M0.04M0.03M955.000.00M
Asset Writedowns and ImpairmentWritedown
-0.13M-0.09M0.00M
Other non-cash itemsOther Non-Cash
1.17M0.05M-0.05M
Change in Working Capital
Change in ReceivablesChange Receivables
-0.04M0.04M-0.02M0.10M0.00M0.01M-0.01M-890.000.03M0.04M0.10M0.01M-0.05M-0.02M-0.03M0.00M0.02M0.00M0.00M-0.01M
Change in InventoryChange Inventory
-0.13M-0.01M0.03M0.01M-0.19M-0.10M-0.01M0.00M0.00M0.00M0.00M-0.01M-0.17M259.00-956.00697.00-0.01M
Change in Accrued ExpensesChange Accrued Exp.
0.22M0.12M0.29M0.00M-0.13M-0.17M0.03M0.14M0.28M0.00M0.10M-0.01M0.13M-0.05M0.07M-0.09M0.10M0.05M0.15M0.14M
Change in Other Operating AssetsOther Assets Change
0.02M-0.12M0.22M0.09M0.15M-0.02M0.10M0.01M-0.02M-0.07M0.03M-0.03M0.11M0.02M-0.01M401.000.01M0.03M-0.03M-0.06M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.06M0.31M0.25M0.11M-0.66M0.33M-0.16M0.22M-0.42M-0.01M0.01M0.08M-0.09M0.08M-635.000.01M0.03M
Other Working Capital ChangesOther WC Changes
-0.08M0.43M0.02M0.02M-0.82M0.35M-0.25M0.21M-0.40M0.07M-0.03M0.11M-0.20M0.07M0.01M0.01M0.02M-0.03M0.03M0.06M
Cash from OperationsCash from Ops.
-0.06M0.05M-0.02M0.06M-0.69M-0.03M-0.15M0.01M-0.56M-0.33M-0.43M0.35M-0.93M-0.39M0.04M-0.36M-0.13M-0.21M-0.08M-157.00
Investing Activities
Capital ExpendituresCapex
0.02M0.01M-0.01M0.02M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.04M-0.08M
Change in Property, Plant and EquipmentChange in PP&E
-0.02M-0.01M0.01M-0.02M0.04M-0.01M-0.08M
Change in IntangiblesChange Intangibless
0.01M
Purchase of InvestmentsInvestments Purchased
0.01M
Cash from Investing ActivitiesCash from Investing
-0.02M-0.01M0.01M-0.04M-0.03M0.11M0.04M-0.01M0.09M-0.08M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
0.21M0.24M-0.45M1.03M0.28M0.20M0.38M0.21M0.08M0.01M
Net Long-Term Debt Issued (Repaid)Net LT Debt
0.21M0.24M-0.45M1.03M0.28M0.20M0.38M0.21M0.08M0.01M
Net Debt Issuances and RepaymentsNet Debt Issuance
0.21M0.24M-0.45M1.03M0.28M0.20M0.38M0.21M0.08M0.01M
Cash from Financing ActivitiesCash from Financing
0.67M0.75M0.31M0.41M-0.42M1.11M0.28M0.20M0.38M0.21M0.08M0.01M
Additional items
Exchange Rate EffectFX Effect
0.05M-0.06M0.03M0.04M-0.05M0.04M0.13M0.00M-0.19M0.10M-0.14M0.03M-0.18M0.12M-0.32M0.36M-0.17M-0.01M0.01M-0.01M
Change in Cash
-0.04M-0.02M0.03M0.05M-0.07M0.01M-0.03M97.000.00M0.05M-0.04M0.00M0.00M0.00M643.00510.000.00M0.00M0.00M0.00M
Beginning Cash Balance
Ending Cash Balance
0.03M0.01M0.04M0.09M0.00M0.02M0.02M0.02M0.00M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Free Cash FlowFCF
-0.08M0.04M-0.01M0.06M-0.69M-0.03M-0.15M0.01M-0.56M-0.35M-0.43M0.35M-0.93M-0.40M0.04M-0.36M-0.13M-0.21M-0.08M-157.00
Net Cash FlowNCF
-0.08M0.04M-0.01M0.02M-0.02M-0.03M-0.15M0.01M0.19M-0.05M0.09M-0.03M0.18M-0.12M0.32M-0.36M0.17M0.01M-0.01M0.01M
Interest Paid
72.00-72.00186.00-186.00101.00-101.00

Yubo International Biotech Cash Flow Statement API

Pull Yubo International Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=YBGJ&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY